TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23085213

Group type: EXPERIMENTAL
Intervention: Community-based physiotherapeutic exercise programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 21451937

Group type: EXPERIMENTAL
Intervention: 8 sets of squat exercise at 80% of 1-RM
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 4 sets of squat exercise at 80% of 1-RM
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: 1 set of squat exercise at 80% of 1-RM
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: All groups (1, 4, and 8 sets)
Number of subjects: 32
Study: 19925973

Group type: COMPARATOR
Intervention: Local anesthetic alone (40 mL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Local anesthetic plus buprenorphine 0.3 mg
Number of subjects: 50
Study: 17000354

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: No treatment (controls)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Comparison between morphine-treated group and controls
Number of subjects: 27
Study: 12680861

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT) with standardized Dermatophagoides pteronyssinus (D.pt.) and D. farinae (D.f.) 50/50 extract
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sublingual-swallow immunotherapy (SLIT)
Number of subjects: 60
Study: 10884864

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) plus Chlorpheniramine (CP) for 3 days
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Chloroquine (CQ) plus Chlorpheniramine (CP) for 3 days followed by Sulfadoxine-Pyrimethamine (SP) on day 4
Number of subjects: 108
Study: 8822974

Group type: EXPERIMENTAL
Intervention: Accelerated tissue plasminogen activator (TPA)
Number of subjects: 41021

Group type: COMPARATOR
Intervention: Streptokinase with subcutaneous heparin
Number of subjects: 41021

Group type: COMPARATOR
Intervention: Streptokinase with intravenous heparin
Number of subjects: 41021

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 41021

Group type: EXPERIMENTAL
Intervention: Accelerated TPA
Number of subjects: 41021
Study: 1559524

Group type: EXPERIMENTAL
Intervention: Low-density (LD) diet (50 kcal/100 g)
Number of subjects: 9

Group type: COMPARATOR
Intervention: High-density (HD) diet (100 kcal/100 g)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Low-density (LD) diet
Number of subjects: 9

Group type: COMPARATOR
Intervention: High-density (HD) diet
Number of subjects: 9
Study: 3999311

Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 5485
Study: 30935225

Group type: EXPERIMENTAL
Intervention: Ultrasound combined with transcutaneous electrical nerve stimulation
Number of subjects: 148

Group type: COMPARATOR
Intervention: Ultrasound (control group)
Number of subjects: 148

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 148
Study: 29860363

Group type: COMPARATOR
Intervention: Standard health check invitation letter only
Number of subjects: 12459

Group type: EXPERIMENTAL
Intervention: QBE questionnaire followed by standard invitation letter
Number of subjects: 12459

Group type: EXPERIMENTAL
Intervention: QBE questionnaire with offer of a financial incentive to return the questionnaire, followed by standard invitation letter
Number of subjects: 12459
Study: 28003127

Group type: EXPERIMENTAL
Intervention: Propranolol administered 60-75 minutes before learning or recall
Number of subjects: 86

Group type: COMPARATOR
Intervention: Propranolol administered immediately after learning or recall
Number of subjects: 86
Study: 26362406

Group type: EXPERIMENTAL
Intervention: Customized nursing intervention providing face-to-face information and emotional support during the examination
Number of subjects: 436

Group type: COMPARATOR
Intervention: Normal care (control group)
Number of subjects: 436

Group type: EXPERIMENTAL
Intervention: Customized nursing intervention
Number of subjects: 436
Study: 23702185

Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) with BCG vaccine
Number of subjects: 1717

Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) without BCG vaccine
Number of subjects: 1717

Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) among children who had not received DTP vaccine
Number of subjects: 1717

Group type: EXPERIMENTAL
Intervention: Neonatal Vitamin A Supplementation (VAS) among children who had received DTP vaccine
Number of subjects: 1717

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1717
Study: 21987698

Group type: EXPERIMENTAL
Intervention: RT-PCR testing with rapid reporting (12 to 36 hours)
Number of subjects: 583

Group type: COMPARATOR
Intervention: Standard hospital protocol with delayed RT-PCR reporting (4 weeks)
Number of subjects: 583
Study: 18291003

Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets (Olyset(R) long-lasting insecticidal bednets)
Number of subjects: 1017

Group type: COMPARATOR
Intervention: Control (untreated sectors)
Number of subjects: 1017
Study: 16784182

Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment
Number of subjects: 22

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 22
Study: 12957348

Group type: EXPERIMENTAL
Intervention: Integrated Family and Cognitive‐Behavioral Therapy (IFCBT)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Drugs Harm Psychoeducation curriculum (DHPE)
Number of subjects: 43
Study: 11138645

Group type: EXPERIMENTAL
Intervention: High-potency, high-frequency fluoride brush-on gel
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: High-potency, high-frequency fluoride gel dentifrice
Number of subjects: 78

Group type: COMPARATOR
Intervention: Low-potency, high-frequency fluoride rinse
Number of subjects: 78
Study: 9298408

Group type: EXPERIMENTAL
Intervention: Total body bioelectrical impedance analysis (BIA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 0
Study: 8333252

Group type: EXPERIMENTAL
Intervention: Selegiline (10 mg per day)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 800
Study: 3549383

Group type: EXPERIMENTAL
Intervention: Proquazone
Number of subjects: 15

Group type: COMPARATOR
Intervention: Indomethacin
Number of subjects: 15

Group type: COMPARATOR
Intervention: Ibuprofen
Number of subjects: 15
Study: 30127143

Group type: EXPERIMENTAL
Intervention: Baseline CST > 500 μm
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Baseline hyper‐reflective dots
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Baseline GCL cystoid spaces
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Neurosensory macular detachments
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: After two injections
Number of subjects: 75
Study: 27515871

Group type: EXPERIMENTAL
Intervention: Spiritist 'passe' energy therapy (8 weekly sessions)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham Spiritist 'passe' sessions (8 weekly sessions)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Spiritist 'passe' energy therapy
Number of subjects: 50
Study: 24375015

Group type: EXPERIMENTAL
Intervention: Daclizumab high-yield process (DAC HYP)
Number of subjects: 88
Study: 21757682

Group type: EXPERIMENTAL
Intervention: Comprehension monitoring strategy (QRAC-the-Code)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Reading independently and noting important points (Control)
Number of subjects: 323
Study: 21235799

Group type: EXPERIMENTAL
Intervention: Knowledge translation strategy involving education, reminders, and audit-feedback
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Knowledge translation strategy
Number of subjects: 37
Study: 18317456

Group type: EXPERIMENTAL
Intervention: Glutamine-enriched parenteral nutrition (GlPN, n=27)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard parenteral nutrition (PN, n=26)
Number of subjects: 53
Study: 16503885

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate (0.05%) cream twice daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment (0.005%) twice daily
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Combination of betamethasone dipropionate (0.05%) in the morning and calcipotriol (0.005%) in the evening
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 49
Study: 12855150

Group type: EXPERIMENTAL
Intervention: Left atrial reduction and mitral surgery (Group I)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isolated valve surgery (Group II)
Number of subjects: 50
Study: 11153584

Group type: EXPERIMENTAL
Intervention: Fish oil capsules containing 84 mg eicosapentaenoic acid (EPA) and 36 mg docosahexaenoic acid (DHA)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control capsules containing 300 mg olive oil
Number of subjects: 29
Study: 9124242

Group type: EXPERIMENTAL
Intervention: Loteprednol etabonate 0.5% ophthalmic suspension
Number of subjects: 223

Group type: COMPARATOR
Intervention: Placebo (loteprednol vehicle)
Number of subjects: 223
Study: 8469251

Group type: EXPERIMENTAL
Intervention: Mechanical valves
Number of subjects: 575

Group type: COMPARATOR
Intervention: Bioprosthetic valves
Number of subjects: 575
Study: 2945833

Group type: EXPERIMENTAL
Intervention: Buddy program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Kids-on-the-Block (KOB) program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Combination of KOB and buddy programs
Number of subjects: 0
Study: 29135277

Group type: EXPERIMENTAL
Intervention: Neuromuscular Manual Therapy (NMT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard Pharmacological Treatment (PT)
Number of subjects: 60
Study: 27910920

Group type: EXPERIMENTAL
Intervention: Three-session radial ESWT (rESWT)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Single-session radial ESWT (rESWT)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Sham eESWT (Control)
Number of subjects: 69
Study: 24647231

Group type: EXPERIMENTAL
Intervention: Abiraterone acetate 1000mg plus prednisone 5mg twice daily
Number of subjects: 1088

Group type: COMPARATOR
Intervention: Prednisone alone
Number of subjects: 1088
Study: 21971352

Group type: EXPERIMENTAL
Intervention: Chronic, high-frequency electrical stimulation of the subthalamic nuclei (STNs)
Number of subjects: 0
Study: 20102835

Group type: EXPERIMENTAL
Intervention: Electronic supermarket sales data
Number of subjects: 49
Study: 18678158

Group type: EXPERIMENTAL
Intervention: Exercise needling and electroacupuncture (EA) at Jianyu (LI 15), Jianliao (TE 14), Jianzhen (SI 9), etc. and TDP
Number of subjects: 120

Group type: COMPARATOR
Intervention: Electroacupuncture (EA) at the same points as the observation group
Number of subjects: 120

Group type: COMPARATOR
Intervention: Oral administration of Fenbid slow-released capsules
Number of subjects: 120
Study: 20499152

Group type: EXPERIMENTAL
Intervention: Risky sexual behaviors within a couple and with concurrent sexual partners
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: STD prevalence for each member of the couple
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Correlates of STDs in male partner
Number of subjects: 535

Group type: EXPERIMENTAL
Intervention: Correlates of STDs in female partner
Number of subjects: 535
Study: 16314227

Group type: EXPERIMENTAL
Intervention: GHRE7.5 (7.5 pmol kg(‐1) min(‐1) acylated human ghrelin)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: GHRE15 (15 pmol kg(‐1) min(‐1) acylated human ghrelin)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 8
Study: 12003435

Group type: EXPERIMENTAL
Intervention: Vitamin K2 (menatetrenone)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 50
Study: 9876949

Group type: EXPERIMENTAL
Intervention: 720 ELISA Units (EL.U) inactivated hepatitis A vaccine, 0, 6‐month schedule
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: 360 ELISA Units (EL.U) inactivated hepatitis A vaccine, 0, 1, 6‐month schedule
Number of subjects: 460
Study: 7978126

Group type: EXPERIMENTAL
Intervention: Antibiotics
Number of subjects: 100

Group type: COMPARATOR
Intervention: Endotoxin antibody (hypothetical intervention)
Number of subjects: 100
Study: 2658359

Group type: EXPERIMENTAL
Intervention: Screening examinations consisting of mammography and a clinical examination of the breast
Number of subjects: 60000

Group type: COMPARATOR
Intervention: Usual medical care
Number of subjects: 60000
Study: 30850756

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 202

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 202
Study: 29927386

Group type: COMPARATOR
Intervention: AL-794 (50-2000 mg single ascending doses)
Number of subjects: 38

Group type: COMPARATOR
Intervention: AL-794 (50-600 mg multiple ascending doses, twice-daily)
Number of subjects: 38

Group type: COMPARATOR
Intervention: AL-794 (450 mg following a high-fat meal)
Number of subjects: 38
Study: 27236344

Group type: COMPARATOR
Intervention: Rubber Band Ligation (RBL)
Number of subjects: 337

Group type: EXPERIMENTAL
Intervention: Haemorrhoidal Artery Ligation (HAL)
Number of subjects: 337
Study: 25301459

Group type: EXPERIMENTAL
Intervention: IN.PACT Amphirion drug‐eluting balloons (IA‐DEB)
Number of subjects: 358

Group type: COMPARATOR
Intervention: Percutaneous transluminal angioplasty (PTA)
Number of subjects: 358
Study: 22730693

Group type: EXPERIMENTAL
Intervention: Xuebejing injection combined with conventional therapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional therapy (control group)
Number of subjects: 16
Study: 20299778

Group type: EXPERIMENTAL
Intervention: Intravesically applied amikacin (1 g in adults and 30 mg/kg in pediatric patients)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Saline solution (control group)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Intravesically applied amikacin
Number of subjects: 200
Study: 17195701

Group type: EXPERIMENTAL
Intervention: Single-dose ceftriaxone
Number of subjects: 1009

Group type: COMPARATOR
Intervention: Oral antibiotics (cefprozil, amoxicillin, azithromycin)
Number of subjects: 1009
Study: 16032532

Group type: EXPERIMENTAL
Intervention: Type 2 diabetes patients with low educational level
Number of subjects: 378

Group type: COMPARATOR
Intervention: Persons without diabetes with low educational level
Number of subjects: 378
Study: 12500659

Group type: EXPERIMENTAL
Intervention: +Zn
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: +ZnCa
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: +ZnCaVA
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: +CaVA
Number of subjects: 156

Group type: COMPARATOR
Intervention: S-control
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: All supplementation groups
Number of subjects: 156
Study: 10074641

Group type: EXPERIMENTAL
Intervention: Standard roller pump (STD)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Dynamically set roller pump (DYN)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Centrifugal pump (CEN)
Number of subjects: 60
Study: 7728693

Group type: EXPERIMENTAL
Intervention: Induction of labour
Number of subjects: 3418

Group type: COMPARATOR
Intervention: Serial antenatal monitoring
Number of subjects: 3418
Study: 2200997

Group type: EXPERIMENTAL
Intervention: Cefotiam 1 g preoperative dose
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cefazoline 3 g perioperatively
Number of subjects: 200
Study: 6993447

Group type: EXPERIMENTAL
Intervention: Trazodone
Number of subjects: 45

Group type: COMPARATOR
Intervention: Imipramine
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30322973

Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of fentanyl: 1 mcg/kg loading dose followed by 1 mcg/kg/hour infusion
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intermittent bolus (IB) doses of fentanyl: 1 mcg/kg/dose every 4 hours
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both CI and IB regimens
Number of subjects: 100
Study: 28981460

Group type: EXPERIMENTAL
Intervention: School-Based Weight Management Program (SBWMP) involving parents via mHealth tools
Number of subjects: 115

Group type: COMPARATOR
Intervention: Usual school planned activities with no parental involvement
Number of subjects: 115
Study: 25648989

Group type: EXPERIMENTAL
Intervention: l-NMMA infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TEA infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: l-NMMA + TEA infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Exercise-induced vasodilation
Number of subjects: 0
Study: 24953015

Group type: EXPERIMENTAL
Intervention: Extrafine beclomethasone dipropionate/formoterol fumarate (BDP/FOR), 100/6 μg pMDI, 2 inhalations BID
Number of subjects: 1186

Group type: COMPARATOR
Intervention: FOR 12 μg pMDI, 1 inhalation BID
Number of subjects: 1186
Study: 22928824

Group type: EXPERIMENTAL
Intervention: Gua Sha therapy (single treatment)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Waiting list control group (WLC)
Number of subjects: 40
Study: 19568208

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise intervention (60%-75% observed maximal HR), for > or = 45 min x d(‐1), 5 d x wk (n = 53)
Number of subjects: 115

Group type: COMPARATOR
Intervention: 1-d x wk(‐1) stretching control (n = 62)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Moderate-intensity aerobic exercise intervention
Number of subjects: 115
Study: 17296407

Group type: EXPERIMENTAL
Intervention: Rotoresection
Number of subjects: 50

Group type: COMPARATOR
Intervention: Transurethral resection
Number of subjects: 50
Study: 15342155

Group type: EXPERIMENTAL
Intervention: Sagittal plane knee joint forces during sidestep cutting
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Valgus loading during sidestep cutting
Number of subjects: 20
Study: 12569977

Group type: EXPERIMENTAL
Intervention: Liposome-entrapped D. pteronyssinus vaccination
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 10099074

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Loratadine (10 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 7915979

Group type: EXPERIMENTAL
Intervention: Dobutamine (5 micrograms/kg/min, n = 5)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Dopexamine (2 micrograms/kg/min, n = 5)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dopexamine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dobutamine
Number of subjects: 10
Study: 2491987

Group type: EXPERIMENTAL
Intervention: Misoprostol (400 micrograms) given at 9 AM and 9:15 PM
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Combined esophageal and gastric pH‐metry
Number of subjects: 7
Study: 793848

Group type: EXPERIMENTAL
Intervention: Metoprolol 75 mg daily (increased to 450 mg max)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Alpha-methyldopa 375 mg daily (increased to 2250 mg max)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Alpha-methyldopa
Number of subjects: 37

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 37
Study: 30222489

Group type: EXPERIMENTAL
Intervention: SUREE without visual feedback
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: SUREE with visual feedback
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 42
Study: 29236887

Group type: EXPERIMENTAL
Intervention: Pilates (n = 22)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Walking (n = 21)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Control (n = 20)
Number of subjects: 63
Study: 25533998

Group type: EXPERIMENTAL
Intervention: 8 mg ramelteon
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 0.125 mg triazolam
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 23727256

Group type: EXPERIMENTAL
Intervention: Small plate size (19.5 cm)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Large plate size (26.5 cm)
Number of subjects: 20
Study: 21838410

Group type: EXPERIMENTAL
Intervention: Duloxetine 60 mg once daily (after starting dose of 30 mg QD for 1 week)
Number of subjects: 527

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 527
Study: 19647467

Group type: EXPERIMENTAL
Intervention: Regular human insulin, administered twice a day for 36 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Observation/control group
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Regular human insulin
Number of subjects: 50
Study: 16762534

Group type: EXPERIMENTAL
Intervention: Milnacipran
Number of subjects: 1082

Group type: COMPARATOR
Intervention: Selective serotonin reuptake inhibitor (SSRI)
Number of subjects: 1082
Study: 14725953

Group type: EXPERIMENTAL
Intervention: Self-report service utilization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Agency records of service utilization
Number of subjects: 0
Study: 11497193

Group type: EXPERIMENTAL
Intervention: Patients with LVH by both Cornell product and Sokolow‐Lyon criteria (n=106)
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Patients with ECG LVH by Cornell product criteria (n=410)
Number of subjects: 906

Group type: EXPERIMENTAL
Intervention: Patients with ECG LVH by Sokolow‐Lyon voltage criteria (n=162)
Number of subjects: 906

Group type: COMPARATOR
Intervention: Patients with only Sokolow‐Lyon voltage criteria
Number of subjects: 906

Group type: COMPARATOR
Intervention: Patients with only Cornell product criteria
Number of subjects: 906

Group type: COMPARATOR
Intervention: Patients with both ECG criteria
Number of subjects: 906
Study: 9806254

Group type: EXPERIMENTAL
Intervention: 5 microg triptorelin acetate s.c. daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 15 microg triptorelin acetate s.c. daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 50 microg triptorelin acetate s.c. daily
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: 100 microg triptorelin acetate s.c. daily
Number of subjects: 48
Study: 7706149

Group type: EXPERIMENTAL
Intervention: Checklist-based training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Professionally developed films
Number of subjects: 48
Study: 2506263

Group type: EXPERIMENTAL
Intervention: Adenosine 5'-monophosphate (AMP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Hypertonic saline
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 14

Group type: COMPARATOR
Intervention: Terfenadine (180 mg)
Number of subjects: 14